Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC TO-I/A Mar 9, 2026 SC TO-I/A
424B3 Mar 3, 2026 424B3
SC TO-I/A Mar 3, 2026 SC TO-I/A
10-K Mar 2, 2026 10-K
8-A12G/A Feb 27, 2026 8-A12G/A
425 Feb 27, 2026 425
8-K Feb 27, 2026 FORM 8-K
SC TO-I/A Feb 27, 2026 SC TO-I/A
SC 14F1 Feb 26, 2026 SC 14F1
SC TO-I/A Feb 11, 2026 SC TO-I/A
425 Feb 11, 2026 425
8-K Feb 11, 2026 FORM 8-K
EFFECT Jan 30, 2026
SCHEDULE 13D/A Jan 30, 2026
SC TO-I Jan 30, 2026 SC TO-I
424B3 Jan 30, 2026 424B3
S-4/A Jan 30, 2026 S-4/A
8-A12G/A Jan 30, 2026 8-A12G/A
8-K Jan 30, 2026 FORM 8-K
CORRESP Jan 28, 2026
S-4 Jan 28, 2026 S-4
UPLOAD Dec 29, 2025
8-A12G/A Dec 23, 2025 8-A12G/A
8-K Dec 23, 2025 FORM 8-K
DRS Dec 19, 2025
← Newer Page 3 of 54 · 1336 filings Older →